Tigatuzumab Biosimilar: Harnessing DR5 for Targeted Cancer Therapy Tigatuzumab is a monoclonal antibody targeting death receptor 5 (DR5), a member of the … read more 17th Dec 2025 Shanza Riaz
Enavatuzumab Biosimilar: Advancing TWEAKR-Targeted Therapy in Cancer Enavatuzumab is a monoclonal antibody targeting TWEAK receptor (TWEAKR, also known as … read more 17th Dec 2025 Shanza Riaz
Alemtuzumab Biosimilar: Advancing CD52-Targeted Therapy Alemtuzumab is a monoclonal antibody targeting CD52, a glycoprotein highly expressed o … read more 17th Dec 2025 Shanza Riaz
Description Description Product Coming SoonIf you have a question, please don't hesitate to get in touch!
Choose Options Quick view Annexin V-PE Reagent MSRP: Now: $251 - $359 Was: Product Code: AKES011 Detection Method: Fluorometric Method
